|

Ozanimod Clinical Trials

3 actively recruiting trials across 3 locations

Also known as: Zeposia

Pipeline

Phase 3: 1Phase 4: 1

Top Sponsors

  • University of Colorado, Denver1
  • Celgene1
  • Biogen1

Indications

  • Multiple Sclerosis3
  • Relapsing Multiple Sclerosis1
  • Multiple Sclerosis, Relapsing-Remitting1

Loma Linda, California1 trial

Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis

Local Institution - 0114

Phase 3

Aurora, Colorado1 trial

Prospective Evaluation of Sequencing From antiCD-20 Therapies to Ozanimod

University of Colorado Anschutz Medical Campus

Phase 4

Eden Prairie, Minnesota1 trial

A Study to Learn More About The Safety of Diroximel Fumarate (VUMERITY®) in Participants Who Took it During Pregnancy And About the Health of Their Babies

OptumInsight

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.